The Cassi II Rotational Core Biopsy System reportedly is the first large core biopsy device on the market that is fully automated, self contained, hand-held and disposable. No capital equipment is required, saving both the expense and associated set-up time to perform a biopsy procedure.
The Visica Treatment System uses cryoablation as a minimally invasive means to surround and destroy a fibroadenoma in a lethal ball of ice. Throughout the procedure, ultrasound visualization provides accurate guidance, added safety and confirmation that the iceball has fully engulfed the fibroadenoma. This safe and effective procedure can be performed in an office in about 30 minutes, using local anesthesia. This "in- office cryoablation technology" destroys fibroadenomas as an alternative to surgical excision.


Additional Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
Subscribe Now